±±¾©Ê¦·¶´óѧϸ°ûÉúÎïѧÊÔÌâÀúÄê»ã×Ü£¨²©Ê¿£©2001Äê-1990Äê(ȱ1997Äê,1998Äê) ",`fGu )
Ò»¡¢ Ãû´Ê½âÊÍ£º ,j9}VnW)
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£©
MCL5a@BX)
2£® PCR£¨96£© f:Ju20D
3£® ·ºËØ£¨ubquitin£©£¨96£© U
hb6{'+
4£® °é·Ö×Ó£¨chapron£©£¨96£© im4V6 f;%
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© r$R(4q:
6£® DG£IP3£¨96£© Dr, {V6^
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© OHM.xw*?.
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© aL+k1v[m
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© "%-HZw%X
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© t<~riFs]
11£® Transformation£¨92£© )5Gzk&|
12£® TransfectionתȾ£¨92£© }4
P@`>e/`
13£® Transcytosis×ªÒÆ×÷Óã¨92£© {cq; SH
14£® Transductionתµ¼£¨92£© Y-gj
X$qGo
15£® Transdetermination£¨92£© >bEH&7+@_'
16£® Transdifferentiation£¨92£© EX=+TOkAf
17£® Transgenic animalת»ùÒò¶¯Î92£© .e"De-u
18£® Rb£1£¨92£© !+JSg uy
19£® P53£¨92¡¢91£© ZRsDn
20£® C£jun£¨92£© leg@ia
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© Q?I)1][ !"
22£® °ûÄÚÌ壨99£© U$ _?T-x
23£® Cyclin dependent kinase inhibitor(CDKI)(99) ZgZ}^x
24£® G£protein£¨91£© m/cbRuPWgP
25£® Restriction point£¨91£© Y%anR|
26£® Antipost£¨91£© [/6$P[
27£® Capping£¨91£© Gxy>aS3
28£® TATAbox£¨91£© FOM~
Uj
29£® cDNA library£¨90£© Haaungb"
30£® Aritotic apparatus£¨90£© ^qIp+[/'
31£® ¿çĤÐźŠtransmembrane signal£¨90£© b+[9)B)a?
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© DN&ZRA
33£® Nuclear lamina£¨90£© 7h&$^
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© gupB8 .!
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© 4+$<G /K
36£® ϸ°û·Ö»¯£¨00£© Olj]A]v}
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© y~SFlv36
38£® ¿Ë¡£¨00£© x98LOO
39£® »ùÒò×飨00£© 6@]Xwq
40£® Caspase£¨00£© fh b &_T
41£® ת¼Òò×Ó£¨00£© i74^J +xk
42£® ÅßÌ¥¸Éϸ°û£¨01£© e%R+IH5i
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© >tr_Ypfv,c
44£® DNAоƬ£¨01£© OV7vwj/-
¶þ¡¢ ÎÊ´ðÌ⣺ 8!VjXj"
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© "<v_fF<Y
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© N5
}vy$t_P
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© pEH[fA]
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© bjm`u3
A
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£©
8kW9.
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© >h[tHM
O
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© $#]?\psf
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© 0
WF(Ga/o
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© n\,TW&3
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© <Ks?g=K-
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© 7 aDI6G
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© <Cg;l<$`b
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© i$"FUC~'
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© PO&xi9_
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© &sS k~:
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© M8KfC!
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© YLSG
5vF+
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© YQQ!1hw
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© )&_{m
K
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© ]\#RsVX
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© (/ k, q
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© Z
#V[N9L
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© HowlJ[ km%
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© k;LENB2iv
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© <}4|R_xY#
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© P]6pPS
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© xHD!8B)
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© ][?GJ"O+U
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© Uj!L:u2b
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£©
VJ=!0v
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© |#-Oz#Eg'
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© B"Fg`s+]U
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© Pc4sReo'
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© 4e%SF|(Y'h
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©